Photo by nickrbolton from unsplash
Maintenance haemodialysis (HD) patients are at higher risk for severe coronavirus disease 2019 (COVID‐19). Because of a limited number of facilities that can provide inpatient treatment for COVID‐19 and HD,… Click to show full abstract
Maintenance haemodialysis (HD) patients are at higher risk for severe coronavirus disease 2019 (COVID‐19). Because of a limited number of facilities that can provide inpatient treatment for COVID‐19 and HD, it is important to identify HD patients who are at high risk for severe COVID‐19. For mild to moderate COVID‐19 patients, chemokine CC‐motif ligand 17 (CCL17) was reported to be a predictive marker for severe COVID‐19; however, the validity of CCL17 among HD patients is unknown.
Keywords:
haemodialysis patients;
severe covid;
chemokine motif;
marker severe;
motif ligand;
predictive marker
Journal Title: Nephrology
Year Published: 2023
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Nephrology
Year Published: 2023
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!